EE200000653A - Bensotiofeenid, bensofuraanid ja indoolid kasutamiseks insuliiniresistentsuse ning hüperglükeemia ravis - Google Patents
Bensotiofeenid, bensofuraanid ja indoolid kasutamiseks insuliiniresistentsuse ning hüperglükeemia ravisInfo
- Publication number
- EE200000653A EE200000653A EEP200000653A EEP200000653A EE200000653A EE 200000653 A EE200000653 A EE 200000653A EE P200000653 A EEP200000653 A EE P200000653A EE P200000653 A EEP200000653 A EE P200000653A EE 200000653 A EE200000653 A EE 200000653A
- Authority
- EE
- Estonia
- Prior art keywords
- benzothiophenes
- benzofurans
- hyperglycaemia
- indoles
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/92—Naphthofurans; Hydrogenated naphthofurans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/74—Naphthothiophenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7671298A | 1998-05-12 | 1998-05-12 | |
PCT/US1999/010209 WO1999061435A1 (en) | 1998-05-12 | 1999-05-10 | Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200000653A true EE200000653A (et) | 2002-04-15 |
Family
ID=22133746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200000653A EE200000653A (et) | 1998-05-12 | 1999-05-10 | Bensotiofeenid, bensofuraanid ja indoolid kasutamiseks insuliiniresistentsuse ning hüperglükeemia ravis |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1077969A1 (zh) |
JP (1) | JP2002516321A (zh) |
KR (1) | KR20010043539A (zh) |
CN (1) | CN1308626A (zh) |
AR (1) | AR015294A1 (zh) |
AU (1) | AU756337B2 (zh) |
BG (1) | BG104918A (zh) |
BR (1) | BR9911779A (zh) |
CA (1) | CA2330620A1 (zh) |
EA (1) | EA200001175A1 (zh) |
EE (1) | EE200000653A (zh) |
HR (1) | HRP20000767A2 (zh) |
HU (1) | HUP0101792A3 (zh) |
ID (1) | ID26244A (zh) |
IL (1) | IL139132A0 (zh) |
NO (1) | NO20005677L (zh) |
PL (1) | PL344081A1 (zh) |
SK (1) | SK16992000A3 (zh) |
TR (1) | TR200003333T2 (zh) |
TW (1) | TW510900B (zh) |
WO (1) | WO1999061435A1 (zh) |
ZA (1) | ZA200005961B (zh) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002018363A2 (en) * | 2000-08-29 | 2002-03-07 | Abbott Laboratories | 3-phenyl-propanoic acid derivatives as protein tyrosine phosphatase inhibitors |
US6472545B2 (en) | 2000-08-29 | 2002-10-29 | Abbott Laboratories | Protein tyrosine phosphatase inhibitors |
WO2002026707A1 (en) * | 2000-09-26 | 2002-04-04 | Biovitrum Ab | Novel compounds |
US6498182B2 (en) | 2000-09-26 | 2002-12-24 | Biovitrum Ab | Compounds |
US6969730B2 (en) | 2001-03-16 | 2005-11-29 | Abbott Laboratories | Amines as histamine-3 receptor ligands and their therapeutic applications |
WO2002098409A1 (en) * | 2001-06-07 | 2002-12-12 | Wyeth | Combination therapy for type ii diabetes or syndrome x |
US20030013709A1 (en) * | 2001-06-07 | 2003-01-16 | Wyeth | Combination of a PTPase inhibitor and an alpha-glucosidase inhibitor |
WO2002098410A1 (en) * | 2001-06-07 | 2002-12-12 | Wyeth | Combination of a ptpase inhibitor and a sulfonylurea agent |
US20020198203A1 (en) * | 2001-06-07 | 2002-12-26 | Wyeth | Combination of a PTPase inhibitor and a thiazolidinedione agent |
WO2002098408A1 (en) * | 2001-06-07 | 2002-12-12 | Wyeth | Ptpase inhibitors for improving cardiovascular risk profile |
WO2002100398A1 (en) * | 2001-06-07 | 2002-12-19 | Wyeth | Combination of a ptpase inhibitor and an ace inhibitor |
WO2002100397A1 (en) * | 2001-06-07 | 2002-12-19 | Wyeth | COMBINATION OF A PTPase INHIBITOR AND AN ANTILIPEMIC AGENT |
US20020198201A1 (en) * | 2001-06-07 | 2002-12-26 | Wyeth | Combination of a PTPase inhibitor and an aldose reductase inhibitor |
WO2002098414A1 (en) * | 2001-06-07 | 2002-12-12 | Wyeth | Methods using ptpase inhibitors and insulin |
US7074817B2 (en) | 2001-06-20 | 2006-07-11 | Wyeth | Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
TWI224101B (en) | 2001-06-20 | 2004-11-21 | Wyeth Corp | Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
US7022730B2 (en) | 2001-10-19 | 2006-04-04 | Transtech Pharma, Inc. | Bis-heteroaryl alkanes as therapeutic agents |
WO2003048140A1 (fr) | 2001-12-03 | 2003-06-12 | Japan Tobacco Inc. | Compose azole et utilisation medicinale de celui-ci |
ITMI20022172A1 (it) * | 2002-10-14 | 2004-04-15 | Clariant Lsm Italia Spa | Processo per la preparazione di 3-alchil-tiofeni-2, 5-disostituiti. |
DE60306548T2 (de) | 2002-12-10 | 2007-06-21 | Wyeth | Substituierte 3-carbonyl-1-yl-essigsäure-derivate als plasminogen aktivator inhibitor(pai-1) inhibitoren |
DE60327550D1 (de) | 2002-12-10 | 2009-06-18 | Wyeth Corp | Substituierte indoloxoacetylaminoessigsäurederivate als inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1) |
UA80453C2 (en) | 2002-12-10 | 2007-09-25 | Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1) | |
DE60306547T2 (de) | 2002-12-10 | 2007-06-28 | Wyeth | Substituierte 3-alkyl- und 3-arylalkyl-1h-indol-1-yl-essigsäure-derivate als plasminogen-aktivator |
EP1569901B1 (en) | 2002-12-10 | 2008-10-15 | Wyeth | ARYL, ARYLOXY, AND ALKYLOXY SUBSTITUTED i 1H /i -INDOL-3-YL GLYOXYLIC ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) |
US7718377B2 (en) | 2003-05-29 | 2010-05-18 | Kyoto Pharmaceutical Industries, Ltd. | Insulin resistance curative and method of screening the same |
US7504401B2 (en) | 2003-08-29 | 2009-03-17 | Locus Pharmaceuticals, Inc. | Anti-cancer agents and uses thereof |
US7446201B2 (en) | 2003-09-25 | 2008-11-04 | Wyeth | Substituted heteroaryl benzofuran acids |
US7265148B2 (en) | 2003-09-25 | 2007-09-04 | Wyeth | Substituted pyrrole-indoles |
US7268159B2 (en) | 2003-09-25 | 2007-09-11 | Wyeth | Substituted indoles |
US7411083B2 (en) | 2003-09-25 | 2008-08-12 | Wyeth | Substituted acetic acid derivatives |
US7332521B2 (en) | 2003-09-25 | 2008-02-19 | Wyeth | Substituted indoles |
US7141592B2 (en) | 2003-09-25 | 2006-11-28 | Wyeth | Substituted oxadiazolidinediones |
US7582773B2 (en) | 2003-09-25 | 2009-09-01 | Wyeth | Substituted phenyl indoles |
US7351726B2 (en) | 2003-09-25 | 2008-04-01 | Wyeth | Substituted oxadiazolidinediones |
US7163954B2 (en) | 2003-09-25 | 2007-01-16 | Wyeth | Substituted naphthyl benzothiophene acids |
US7442805B2 (en) | 2003-09-25 | 2008-10-28 | Wyeth | Substituted sulfonamide-indoles |
US7342039B2 (en) | 2003-09-25 | 2008-03-11 | Wyeth | Substituted indole oximes |
US7420059B2 (en) | 2003-11-20 | 2008-09-02 | Bristol-Myers Squibb Company | HMG-CoA reductase inhibitors and method |
FR2862645B1 (fr) * | 2003-11-20 | 2007-06-22 | Merck Sante Sas | Composes antidiabetiques contenant des derives benzofuranes, benzothiophenes |
KR20070055563A (ko) | 2004-08-23 | 2007-05-30 | 와이어쓰 | 혈전증 및 심혈관 질병의 치료에 유용한 플라스미노겐활성화제 억제제 타입-1(pai-1)의 조절제로서의옥사졸로-나프틸 산 |
CN101263115A (zh) | 2005-08-17 | 2008-09-10 | 惠氏公司 | 经取代吲哚和其用途 |
JP5546451B2 (ja) | 2007-06-04 | 2014-07-09 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸の障害、炎症、癌および他の障害の処置に有用なグアニル酸シクラーゼのアゴニスト |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
AU2009256157B2 (en) | 2008-06-04 | 2014-12-18 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
WO2010009319A2 (en) | 2008-07-16 | 2010-01-21 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
GB0822486D0 (en) * | 2008-12-10 | 2009-01-14 | Univ Liverpool | Compounds for use in the treatment of pain |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
WO2014057522A1 (en) | 2012-10-12 | 2014-04-17 | Mochida Pharmaceutical Co., Ltd. | Compositions and methods for treating non-alcoholic steatohepatitis |
WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
US10441560B2 (en) | 2013-03-15 | 2019-10-15 | Mochida Pharmaceutical Co., Ltd. | Compositions and methods for treating non-alcoholic steatohepatitis |
CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
EP2968245B1 (en) | 2013-03-15 | 2021-05-05 | Mochida Pharmaceutical Co., Ltd. | Compositions and methods for treating non-alcoholic steatohepatitis |
US10011637B2 (en) | 2013-06-05 | 2018-07-03 | Synergy Pharmaceuticals, Inc. | Ultra-pure agonists of guanylate cyclase C, method of making and using same |
CN106749169B (zh) * | 2016-11-07 | 2020-04-21 | 浙江工业大学 | 一种Ertiprotafib的手性制备方法 |
CN107033122B (zh) * | 2017-05-19 | 2019-06-14 | 南方医科大学 | 一种n-芳基-2-噻吩酰胺类衍生物及其制备方法和用途 |
US20210115397A1 (en) | 2018-04-26 | 2021-04-22 | Tokyo Institute Of Technology | Method for promoting differentiation of pluripotent stem cells |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2015724B1 (zh) * | 1968-08-15 | 1973-01-12 | Parke Davis & Co | |
US3639422A (en) * | 1969-07-28 | 1972-02-01 | Parke Davis & Co | 4-phenylindole-1 (and 7)-acetic acids |
US3682976A (en) * | 1970-02-16 | 1972-08-08 | Parke Davis & Co | Phenyl benzofuran acetic acid compounds |
GB8417559D0 (en) * | 1984-07-10 | 1984-08-15 | Pfizer Ltd | Anti-diarrhoeal agents |
FR2599740B1 (fr) * | 1986-06-05 | 1988-08-12 | Rhone Poulenc Sante | Derives de benzo(b)thiophene de benzo(b)furannecarboxamides, leurs procedes de preparation et les medicaments les contenant |
JPH01135766A (ja) * | 1987-11-20 | 1989-05-29 | Tanabe Seiyaku Co Ltd | ビフェニル誘導体 |
US5110825A (en) * | 1989-12-28 | 1992-05-05 | Shionogi & Co., Ltd. | Benzofuran derivative |
US5340833A (en) * | 1992-05-01 | 1994-08-23 | Eisai Co., Ltd. | Urokinase inhibitors |
DE4425613A1 (de) * | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
-
1999
- 1999-05-10 HU HU0101792A patent/HUP0101792A3/hu unknown
- 1999-05-10 CN CN99808367A patent/CN1308626A/zh active Pending
- 1999-05-10 PL PL99344081A patent/PL344081A1/xx not_active Application Discontinuation
- 1999-05-10 AU AU38939/99A patent/AU756337B2/en not_active Ceased
- 1999-05-10 EA EA200001175A patent/EA200001175A1/ru unknown
- 1999-05-10 WO PCT/US1999/010209 patent/WO1999061435A1/en not_active Application Discontinuation
- 1999-05-10 TR TR2000/03333T patent/TR200003333T2/xx unknown
- 1999-05-10 EE EEP200000653A patent/EE200000653A/xx unknown
- 1999-05-10 EP EP99921829A patent/EP1077969A1/en not_active Withdrawn
- 1999-05-10 SK SK1699-2000A patent/SK16992000A3/sk unknown
- 1999-05-10 KR KR1020007012649A patent/KR20010043539A/ko not_active Application Discontinuation
- 1999-05-10 JP JP2000550841A patent/JP2002516321A/ja active Pending
- 1999-05-10 IL IL13913299A patent/IL139132A0/xx unknown
- 1999-05-10 ID IDW20002311A patent/ID26244A/id unknown
- 1999-05-10 BR BR9911779-7A patent/BR9911779A/pt not_active IP Right Cessation
- 1999-05-10 TW TW088107532A patent/TW510900B/zh active
- 1999-05-10 CA CA002330620A patent/CA2330620A1/en not_active Abandoned
- 1999-05-12 AR ARP990102229A patent/AR015294A1/es unknown
-
2000
- 2000-10-24 ZA ZA200005961A patent/ZA200005961B/xx unknown
- 2000-11-07 BG BG104918A patent/BG104918A/bg unknown
- 2000-11-10 HR HR20000767A patent/HRP20000767A2/hr not_active Application Discontinuation
- 2000-11-10 NO NO20005677A patent/NO20005677L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20010043539A (ko) | 2001-05-25 |
AR015294A1 (es) | 2001-04-18 |
AU3893999A (en) | 1999-12-13 |
NO20005677D0 (no) | 2000-11-10 |
TR200003333T2 (tr) | 2001-02-21 |
EP1077969A1 (en) | 2001-02-28 |
HRP20000767A2 (en) | 2001-10-31 |
ID26244A (id) | 2000-12-07 |
EA200001175A1 (ru) | 2001-06-25 |
JP2002516321A (ja) | 2002-06-04 |
IL139132A0 (en) | 2001-11-25 |
PL344081A1 (en) | 2001-09-24 |
HUP0101792A2 (hu) | 2002-01-28 |
SK16992000A3 (sk) | 2001-04-09 |
HUP0101792A3 (en) | 2003-01-28 |
CA2330620A1 (en) | 1999-12-02 |
ZA200005961B (en) | 2001-10-24 |
BG104918A (bg) | 2001-08-31 |
NO20005677L (no) | 2000-12-05 |
WO1999061435A1 (en) | 1999-12-02 |
CN1308626A (zh) | 2001-08-15 |
BR9911779A (pt) | 2001-02-06 |
AU756337B2 (en) | 2003-01-09 |
TW510900B (en) | 2002-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200000653A (et) | Bensotiofeenid, bensofuraanid ja indoolid kasutamiseks insuliiniresistentsuse ning hüperglükeemia ravis | |
NO991186L (no) | Bruk av leptinantagonister for behandling av insulinresistens ved type-II-diabetes | |
PT1322163E (pt) | Tratamento de sementes com combinacoes de piretrinas/piretroides e clotianidina | |
DE60033051D1 (de) | Methode und einrichtung zur kontinuierlichen herstellung von diarylcarbonaten | |
HK1037981A1 (en) | Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis C. | |
DE69921429D1 (de) | Dreh- und steuerbares Bohrsystem mit Schiebehülse | |
DE69727345D1 (de) | Substratbehandlungsanordnung, Substratübertragungsanordnung und Methode | |
NO20013883D0 (no) | Frysetorket middel inneholdende paramylon, samt fremgangsmate og anvendelse derav | |
EE200100437A (et) | C-21 modifitseeritud epotioloonid, nende valmistamise meetod ning kasutamine | |
EE200100391A (et) | Peptidüül-heterotsüklilised ketoonid, nende kasutamine ja farmatseutiline kompositsioon | |
EE200200414A (et) | Dihüdro-1,3,5-triasiinamino derivaadid ja nende kasutamine ravis | |
NO20005990D0 (no) | Platinumkompleks, dets fremstilling og terapeutiske anvendelse | |
MX238203B (es) | Tratamiento de semillas con combinaciones de piretrinas, piretroides y tlametoxam. | |
DE60035497D1 (de) | Verfharen zur konservierung von viren und mycoplasma | |
EE04490B1 (et) | Ühend, selle valmistamise meetod ning kasutamine meditsiinis | |
DE69923044D1 (de) | Gewebebehandlungsmittel, Gewebe, Textildruckverfahren sowie Druck | |
FI980472A (fi) | Latausmenetelmä ja -järjestely | |
ATE337321T1 (de) | Cabapenemderivate, ihre anwendung und ihre zwischenprodukte | |
EE03667B1 (et) | Alfa -2 - adrenotseptori antagonisti, selle derivaadi kasutamine ravimi valmistamiseks vaimuhaiguseravimiseks imetajatel ja kompositsioon selle tarvis | |
FI981475A0 (fi) | Menetelmät, laitteet ja kuvausmoodi tomografiakuvantamisessa | |
FI981476A0 (fi) | Menetelmä, laite ja niiden käyttö tomografiakuvantamisessa | |
NO20005919L (no) | Platinakompleks, dets fremstilling og terapeutisk anvendelse | |
DE69735123D1 (de) | Trehalose phosphorylase, deren Herstellung und Verwendung | |
EP1117675A4 (en) | THE KADHERING SIMILAR PROTEIN AND METHOD FOR ITS MANUFACTURE | |
FI981477A (fi) | Menetelmä, laite ja niiden käyttö tomografiakuvantamisessa |